Skip to main content
Signal8

Primus Guy Warren

SEC insider (Form 3/4/5 filer). CIK 0002085122. Director at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in BOCA RATON, FL.

Companies Primus Guy Warren has filed insider reports for

  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT): Director
Primus Guy Warren profile photo

Primus Guy Warren

CIK: 0002085122

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LIXTE BIOTECHNOLOGY HOLDINGS, INC. logo
LIXT

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. logo
    LIXT

    LIXTE BIOTECHNOLOGY HOLDINGS, INC.

    Jul 1, 2026
    Award
    Direct
    15K shares-
  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. logo
    LIXT

    LIXTE BIOTECHNOLOGY HOLDINGS, INC.

    Apr 15, 2026
    Award
    Direct
    25K shares-
  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. logo
    LIXT

    LIXTE BIOTECHNOLOGY HOLDINGS, INC.

    Apr 15, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    25K shares-
  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. logo
    LIXT

    LIXTE BIOTECHNOLOGY HOLDINGS, INC.

    Dec 24, 2025
    Award

    Stock Option (right to buy)

    Direct
    25K shares-

1-4 of 4